NQO1 and brain neoplasm: Furthermore, due to selectivity, potency, pharmacokinetic properties, and the ready availability of diagnostics for assessing NQO1 in patients, some NQO1 substrates such as deoxynyboquinone, have considerable potential as personalized medicines for the treatment of various disorders, such as brain tumors [278].